Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:50 pm Unchanged | 2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | CAXTON CORP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:30 pm Purchase | 2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF | CAXTON CORP | 3,098,447 8.800% | 1,140,204 (+58.23%) | Filing History |
| 2020-10-14 1:52 pm Purchase | 2020-10-08 | 13G | Rezolute, Inc. RZLT | CAXTON CORP | 564,243 6.600% | 564,243 (New Position) | Filing History |
| 2020-10-01 5:55 pm Purchase | 2020-02-13 | 13G | CTI BioPharma Corp. CTIC | CAXTON CORP | 4,487,317 6.100% | 4,487,317 (New Position) | Filing History |
| 2020-09-23 10:37 am Purchase | 2020-09-17 | 13D | Strongbridge Biopharma plc SBBP | CAXTON CORP | 10,280,682 15.200% | 1,765,853 (+20.74%) | Filing History |